COMPANY PROFILE

Theradaptive

Revolutionizing the field of therapeutic delivery with a pipeline of first-in-class and best-in-class products that address an $80B global market

Frederick, United StatesFounded 2017Biotech & Life Sciences

Valuation $100–250M Last recorded · 2026

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Theradaptive

Theradaptive is a biotechnology company focused on developing advanced therapeutic delivery systems to improve the efficacy and safety of treatments. The company specializes in creating material binding variants of recombinant proteins for use in a variety of clinical indications, including spinal fusion, orthopedics, soft tissue repair, and targeted chemotherapeutics. By enhancing the precision of therapeutic delivery, Theradaptive aims to reduce off-target side effects and improve patient outcomes.

Theradaptive serves healthcare providers, medical institutions, and pharmaceutical companies operating in the biotechnology and medical sectors. The company’s business model revolves around research and development, clinical trials, and partnerships with other medical and pharmaceutical entities. Revenue is generated through licensing agreements, product sales, and collaborative research funding.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2017
Headquarters: Frederick, United States
Employees: 36
Open positions: 7
Dealroom signal: 82.7/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Precision Medicine, Spinout, Biotech and Pharma, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

8 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
EARLY VC✓Equity / VC	Aug 2026	$36M	$145M	Undisclosed	↗
GRANT✓Other financing	Jun 2026	$465K	—	State of Maryland	↗

Showing the latest 2 of 8 recorded eventsBook a demo for the full funding history →

Growth signals

Theradaptive website traffic

Latest recorded traffic for Theradaptive is 1.9K monthly website visits, up 35.7% over the last three months. Theradaptive's team grew 12.5% over the past year.

Latest monthly visits1.9K 3-month web change+35.7% 1-year team growth+12.5%

Monthly website visitsJan 2021–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

MSAT Bioprocess Engineer III / IVFrederick, MD · Other · Aug 3, 2026 Material HandlerFrederick, MD · Logistics · Jul 25, 2026 Sr. Research Associate, Analytical DevelopmentFrederick, MD · Other · Jul 6, 2026 Office AdministratorFrederick, MD · Human Resources · Jul 2, 2026

4 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
HTHalda TherapeuticsPrecision oncology therapies targeting cancer via RIPTAC™ chimera	New Haven, United States	Acquired	40	$126M	$3B
VBVector BioPharmaCutting-edge gene precision delivery technology that will transform the safety, efficacy, and specificity of biologics	Basel, Switzerland	Closed
YTYsotope TheranosticsTargeted radiopharmaceuticals for precision oncology	Madrid, Spain	Operational
TBTome BiosciencesTome Biosciences is the programmable gene insertion company	Watertown, United States	Operational
AVAviadoBioPrecision gene therapies for neurodegenerative disorders	London, United Kingdom	Operational
ATAthos therapeuticsPioneering the Development of Artificial Intelligence-based Precision Therapeutics for Chronic Inflammatory Diseases	Torrance, United States	Operational
XIXsphera Biosciences IncPrecision ex vivo profiling to predict patient responses to oncology therapeutics	Boston, United States	Operational
EVevidnetProvides evidence-based medicine to patients	Seoul, South Korea	Operational